Literature DB >> 24244928

Natural Killer cell-dependent and non-dependent anti-viral activity of 2-Cys Peroxiredoxin against HIV.

Mohammed Asmal1, Norman L Letvin, Ralf Geiben-Lynn.   

Abstract

2-cys peroxiredoxins (Prx), a group of anti-oxidative enzyme proteins, act directly on virally-infected cells to inhibit HIV-1 replication, and indirectly through destruction of HIV infected cells by stimulation of Natural Killer (NK) cell-mediated immune responses. We assayed for antibody-dependent NK cell mediated viral inhibition (ADCVI) using plasma from SIV-infected rhesus macaques. We found that Prx-1 strongly increased ADCVI in a dose-dependent manner, suggesting augmentation of NK cell killing. We also investigated the effect of Prx-1 on NK cell-independent HIV-1 and HIV-2 inhibition. We found that primary HIV isolates were potently inhibited at nM concentrations, regardless of viral clade, receptor usage or anti-retroviral drug resistance. During NK cell independent inhibition, we found that Prx-1 reversed the HIV-1 induced gene expression of Heat shock protein 90 kDa alpha (cystolic), class A member 2, (HSP90), a protein of the stress pathway. Prx-1 highly activated Cyclin-dependent kinase inhibitor 2B (CDKN2B), a gene of the TGF-β pathway, and Baculoviral IAP repeat-containing 2 (Birc-2), an anti-apoptotic gene of the NF-κB pathway. We identified gene-expression networks highly dependent on the NFκB and ERK1/2 pathways. Our findings demonstrate that Prx-1 inhibits HIV replication through NK cell-dependent and NK cell-independent mechanisms.

Entities:  

Keywords:  Antibody-dependent NK cell mediated viral inhibition; HIV; NK cell independent HIV inhibition peroxiredoxin

Year:  2013        PMID: 24244928      PMCID: PMC3826819     

Source DB:  PubMed          Journal:  Int Trends Immun


  35 in total

1.  Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.

Authors:  Donald N Forthal; Gary Landucci; Kelly Stefano Cole; Marta Marthas; Juan C Becerra; Koen Van Rompay
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  T lymphocytes and dendritic cells are activated by the deletion of peroxiredoxin II (Prx II) gene.

Authors:  Eun-Yi Moon; Young-Wook Noh; Ying-Hao Han; Sun-Uk Kim; Jin-Man Kim; Dae-Yeul Yu; Jong-Seok Lim
Journal:  Immunol Lett       Date:  2005-10-21       Impact factor: 3.685

3.  Modeling combinations of antiretroviral agents in vitro with integration of pharmacokinetics: guidance in regimen choice for clinical trial evaluation.

Authors:  G L Drusano; M Prichard; P A Bilello; J A Bilello
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

Review 4.  Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling.

Authors:  Sue Goo Rhee; Ho Zoon Chae; Kanghwa Kim
Journal:  Free Radic Biol Med       Date:  2005-03-24       Impact factor: 7.376

5.  Differential role of peroxiredoxin II (PrxII) on the expression of toll-like receptor 4 (TLR4) and B-cell activating factor (BAFF) in ovalbumin (OVA)-induced mouse asthma.

Authors:  Eun-Yi Moon; Jong Soon Kang; Seung Hyun Han; Kyu-Hwan Yang; Suhkneung Pyo; Mi-Young Lee; Hyung-Kyu Lee; Dae-Yeul Yu
Journal:  Int Immunopharmacol       Date:  2008-02-26       Impact factor: 4.932

6.  Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate.

Authors:  Wendy W Yeh; Pimkwan Jaru-Ampornpan; Daiva Nevidomskyte; Mohammed Asmal; Srinivas S Rao; Adam P Buzby; David C Montefiori; Bette T Korber; Norman L Letvin
Journal:  J Virol       Date:  2009-01-07       Impact factor: 5.103

7.  HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts.

Authors:  J F Di Mari; J I Saada; R C Mifflin; J D Valentich; D W Powell
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-07-19       Impact factor: 4.052

8.  Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate.

Authors:  M Thivierge; C Le Gouill; M J Tremblay; J Stanková; M Rola-Pleszczynski
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113

9.  Novel roles of peroxiredoxins in inflammation, cancer and innate immunity.

Authors:  Tetsuro Ishii; Eiji Warabi; Toru Yanagawa
Journal:  J Clin Biochem Nutr       Date:  2012-02-18       Impact factor: 3.114

10.  In vivo anti-HIV activity of the heparin-activated serine protease inhibitor antithrombin III encapsulated in lymph-targeting immunoliposomes.

Authors:  Mohammed Asmal; James B Whitney; Corinne Luedemann; Angela Carville; Robert Steen; Norman L Letvin; Ralf Geiben-Lynn
Journal:  PLoS One       Date:  2012-11-02       Impact factor: 3.240

View more
  2 in total

1.  Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women.

Authors:  Julie F Weis; R Scott McClelland; Walter Jaoko; Kishor N Mandaliya; Julie Overbaugh; Susan M Graham
Journal:  AIDS Res Hum Retroviruses       Date:  2014-11-13       Impact factor: 2.205

2.  Adenanthin, a new inhibitor of thiol-dependent antioxidant enzymes, impairs the effector functions of human natural killer cells.

Authors:  Marta Siernicka; Magdalena Winiarska; Malgorzata Bajor; Malgorzata Firczuk; Angelika Muchowicz; Malgorzata Bobrowicz; Cyril Fauriat; Jakub Golab; Daniel Olive; Radoslaw Zagozdzon
Journal:  Immunology       Date:  2015-07-08       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.